Liu Zhong, Hu Boqiang, Zeng Tao, You Cuiping, Li Nan, Liu Yongjing, Zhang Jie, Liu Chenbing, Jin Piaopiao, Feng Xiaoxi, Chen Jun, Huang Jinyan
Center for Health Management, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China.
Biomedical Big Data Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China.
EBioMedicine. 2025 Feb;112:105549. doi: 10.1016/j.ebiom.2024.105549. Epub 2025 Jan 2.
Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2 virus infection, is characterized as a multisystem disease, potentially yielding multifaceted consequences on various organs at multiple levels. At the end of 2022, over 90% of the Chinese population was infected by SARS-CoV-2 within 35 days because of adjustments to epidemic prevention and control policies. This short-term change provides an unprecedented opportunity for comparative studies on COVID-19 infection among large populations.
In this study, the physical examination data of 136,713 people in the past three consecutive years was employed to study the impact of COVID-19. Standard physical examination data, comprising evaluations of nearly a hundred indicators, were investigated for a comprehensive assessment of COVID-19's effect on human health.
The results suggested that most indicators remained stable or changed within a permissible range after the COVID-19 outbreak in December 2022, but several specific indicators presented abnormal patterns of varying durations. There was an observed increase in the fraction of T-wave abnormalities during the outbreak, especially in people with chronic diseases such as hypertension, liver steatosis, and hyperglycemia.
These findings highlighted the impact of COVID-19 on cardiovascular health and its potential interaction with chronic diseases.
This work was supported by the National Key Research and Development Program of China (2019YFE0108100), the National Natural Science Foundation of China General Program (82270159, 82070147).
2019冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒感染引起,是一种多系统疾病,可能在多个层面上对各个器官产生多方面的影响。2022年底,由于疫情防控政策的调整,超过90%的中国人口在35天内感染了SARS-CoV-2。这一短期变化为大规模人群中COVID-19感染的比较研究提供了前所未有的机会。
在本研究中,采用连续三年136713人的体检数据来研究COVID-19的影响。对包括近百项指标评估的标准体检数据进行调查,以全面评估COVID-19对人类健康的影响。
结果表明,2022年12月COVID-19疫情爆发后,大多数指标保持稳定或在允许范围内变化,但有几个特定指标呈现出不同持续时间的异常模式。疫情期间观察到T波异常比例增加,尤其是在患有高血压、肝脂肪变性和高血糖等慢性病的人群中。
这些发现突出了COVID-19对心血管健康的影响及其与慢性病的潜在相互作用。
本研究得到了国家重点研发计划(2019YFE0108100)、国家自然科学基金面上项目(82270159、82070147)的支持。